Your browser doesn't support javascript.
loading
Cost-utility analysis of the universal pneumococcal vaccination programme for older adults in Norway.
Nymark, Liv Solvår; Dag Berild, Jacob; Lyngstad, Trude Marie; Askeland Winje, Brita; Frimann Vestrheim, Didrik; Aaberge, Ingeborg; Juvet, Lene Kristine; Wolff, Ellen.
Afiliação
  • Nymark LS; Division of Infection ControL, Norwegian Institute of Public Health, Oslo, Norway.
  • Dag Berild J; Division of Infection ControL, Norwegian Institute of Public Health, Oslo, Norway.
  • Lyngstad TM; Division of Infection ControL, Norwegian Institute of Public Health, Oslo, Norway.
  • Askeland Winje B; Division of Infection ControL, Norwegian Institute of Public Health, Oslo, Norway.
  • Frimann Vestrheim D; Division of Infection ControL, Norwegian Institute of Public Health, Oslo, Norway.
  • Aaberge I; Division of Infection ControL, Norwegian Institute of Public Health, Oslo, Norway.
  • Juvet LK; Division of Infection ControL, Norwegian Institute of Public Health, Oslo, Norway.
  • Wolff E; Department of Public Health Analysis and Data Management, Public Health Agency of Sweden, Solna, Sweden.
Hum Vaccin Immunother ; 18(6): 2101333, 2022 Nov 30.
Article em En | MEDLINE | ID: mdl-35917277
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Pneumocócicas / Vacinas Pneumocócicas Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções Pneumocócicas / Vacinas Pneumocócicas Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article